U.S. Specialty Stores Stock News

If you’ve ever wondered whether CNX Resources is a bargain or priced for perfection, you’re not alone. Figuring that out is where smart investing starts. Despite a tough year with the stock down 8.3% over the last 12 months, short-term performance is turning around, up 7.1% just this week. Recent news has focused on increased natural gas demand forecasts and shifting analyst sentiment, which are fueling renewed interest in energy stocks like CNX. Momentum from policy changes around domestic...

Kosmos Energy Ltd. ( NYSE:KOS ) shareholders that were waiting for something to happen have been dealt a blow with a...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are drifting lower this morning as investors weigh a jump in long-term bond yields and a new record for household debt. The prospect of higher borrowing costs and elevated debt levels is spurring fresh caution across the market and putting pressure on consumer-focused stocks, as investors focus on the risk that financial strain could temper the economy’s momentum. Act now to uncover undervalued stocks based on...

The subdued stock price reaction suggests that Envista Holdings Corporation's ( NYSE:NVST ) strong earnings didn't...

Wondering if Watsco is worth a closer look for your portfolio? You are not alone, as many investors are trying to figure out whether the current price reflects real value or lurking risks. Watsco stock has slipped recently, down 2.8% in the last week and 12.7% over the past month, adding up to a year-to-date drop of 23.7%. That is a notable turn considering the stock had delivered gains of 52.5% over three years and 76.4% over five years. However, it is now sitting 28.9% lower than a year...

AES (AES) posted earnings growth of 9.7% over the past year, a step down from its striking 56.4% per year average over the past five years. Net profit margins improved to 7.6%, compared to 6.7% a year earlier. Shares currently trade at $14.22, notably below the estimated fair value of $19.28. With the company’s Price-To-Earnings ratio of 11x standing well below sector averages, investors will likely weigh discounted valuation against questions around the sustainability and quality of recent...

SNDL (NasdaqCM:SNDL) has released its third quarter and nine month earnings for 2025, revealing higher sales and a narrower net loss compared to the same periods last year. These updates are sparking fresh investor interest. See our latest analysis for SNDL. SNDL’s share price has been on a rollercoaster this year. After a rally earlier in the quarter, it’s taken a breather with a 27.7% drop over the past month and a 14.4% fall in the last week, despite the latest earnings showing meaningful...

Wondering if Capital Southwest is a hidden gem or overpriced? You are not alone. We are here to dig deeper into whether the numbers suggest real value. The stock recently closed at $20.57. While it has delivered a modest 2.5% return over the last year, the previous five years saw a dramatic 130.7% climb. This hints at shifting risk perspectives and growth potential. Investors have been keeping an eye on Capital Southwest after new developments in the diversified...

Stem, Inc.'s ( NYSE:STEM ) solid earnings report last week was underwhelming to investors. We think that they may be...

Curious if Papa John's International stock is a value opportunity or a value trap? Let's dig into what the numbers and recent activity suggest for would-be investors. The share price has seen some turbulence lately, dropping 21.3% in the last week and 11.4% over the last month. This might hint at shifting market sentiment or new risks emerging. Growing concerns about shifting consumer trends and competitive pressures have weighed on the stock recently, drawing extra attention from both bulls...

Wondering if DexCom is a bargain or just priced for perfection? If you have questions about what the stock is really worth, you are not alone. DexCom shares have seen notable swings lately, dropping 13.1% over the past week and falling 24.5% year-to-date. This could signal shifting market sentiment or emerging opportunities. Recently, DexCom made headlines after the company launched its next-generation G7 continuous glucose monitoring system in more markets, and a major competitor announced...

Boise Cascade Company ( NYSE:BCC ) last week reported its latest third-quarter results, which makes it a good time for...

United Therapeutics recently announced the first clinical xenotransplantation of its UKidney™ in patients with end-stage renal disease at NYU Langone Health, as part of the multicenter EXPAND study designed to support regulatory approval. This milestone introduces the potential to address organ shortages for thousands of patients on transplant waiting lists, signaling a potential shift in transplant medicine. We'll explore how this breakthrough in clinical xenotransplantation could reshape...

Associated Banc-Corp recently reported strong third quarter earnings, announcing net income of US$124.73 million and a quarterly dividend increase to US$0.24 per common share as of October 2025, while also opening a new flagship IDS Center branch in downtown Minneapolis. The earnings release highlighted significant year-over-year profit growth, reflecting both enhanced operational performance and a focus on returning value to shareholders through a higher dividend. We'll explore how the...

Rani Therapeutics Holdings (RANI) just made headlines with a new licensing agreement with Chugai Pharmaceutical. This deal brings over $1 billion in potential revenue for its RaniPill technology and boosts its financial flexibility. See our latest analysis for Rani Therapeutics Holdings. Momentum around Rani Therapeutics Holdings has accelerated sharply, with a 1-month share price return of nearly 400% and year-to-date gains over 70%. This reflects investor excitement after its Chugai deal...

Shareholders appeared unconcerned with Columbia Sportswear Company's ( NASDAQ:COLM ) lackluster earnings report last...

Hamilton Lane and The Guardian Life Insurance Company of America recently announced a long-term partnership, under which Hamilton Lane will oversee Guardian's nearly US$5 billion private equity portfolio and secure annual investment commitments of approximately US$500 million for the next decade, including US$250 million in seed capital for new Evergreen initiatives. This agreement, alongside the release of Hamilton Lane's latest quarterly results showing year-over-year revenue and net...

It's not a stretch to say that Natural Health Trends Corp.'s ( NASDAQ:NHTC ) price-to-sales (or "P/S") ratio of 0.9x...

Kratos Defense & Security Solutions (KTOS) posted a net profit margin of 1.2%, up from 0.9% a year ago. Annual earnings growth reached 46.7%, surpassing its five-year average. Revenue growth is forecast at 13.9% per year, which is higher than the broader US market's 10.4%. Earnings are expected to rise by 37.4% annually, also outpacing the market. Profit and margin improvements present an encouraging signal about continued momentum, though the current Price-to-Sales Ratio of 10.8x remains...

Westamerica Bancorporation (WABC) shares edged higher in recent trading, prompting some investors to take a closer look at the bank’s stock performance and valuation. As market sentiment shifts, WABC’s track record and financials are once again under review. See our latest analysis for Westamerica Bancorporation. After a challenging stretch for regional banks, Westamerica Bancorporation’s recent uptick suggests sentiment may be slowly shifting. While its 1-year total shareholder return is...

Investors were disappointed with Riot Platforms, Inc.'s ( NASDAQ:RIOT ) earnings, despite the strong profit numbers. We...

Aptiv (APTV) sparked investor interest after raising its full-year earnings guidance following a challenging third quarter, which was marked by significant goodwill impairment charges. The company’s focus on a planned software business spin-off is also drawing attention. See our latest analysis for Aptiv. Despite some headline-grabbing challenges earlier in the year, Aptiv's momentum has picked up speed. Its share price has surged 27% over the past 90 days and climbed nearly 39% for the...

Insiders who bought US$337.9k worth of Magnachip Semiconductor Corporation's ( NYSE:MX ) stock at an average buy price...